Trial intelligence / Profile preview

Bisphosphonate to preserve bone volume in transplanted jaw bone

2014-003817-28Phase 3Completed

Sponsor
Region Östergötland
Start
Mar 2015
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in Jaw abnormality comparing Ibandronic acid (Bondronat) with Placebo (2 arms). Primary endpoint: Bone volume change in transplanted jaw bone. Started Mar 2015; status: completed.

02

Drugs

ibandronic acid
03

Conditions

Jaw abnormality

Beyond the preview

Go deeper on 2014-003817-28.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2014-003817-28.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call